156 related articles for article (PubMed ID: 10022555)
21. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
22. Intra-arterial virus and nonvirus vector-mediated gene transfer to experimental rat brain tumors.
Rainov NG; Ikeda K; Qureshi N; Grover S; Barnett FH; Herrlinger U; Quinones A; Chiocca EA; Breakefield XO
Front Radiat Ther Oncol; 1999; 33():227-40. PubMed ID: 10549492
[No Abstract] [Full Text] [Related]
23. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V
Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986
[TBL] [Abstract][Full Text] [Related]
24. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
25. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
Manome Y; Kunieda T; Wen PY; Koga T; Kufe DW; Ohno T
Hum Gene Ther; 1998 Jul; 9(10):1409-17. PubMed ID: 9681412
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma.
Mae M; Crystal RG
Hum Gene Ther; 2002 Aug; 13(12):1471-82. PubMed ID: 12215268
[TBL] [Abstract][Full Text] [Related]
27. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
28. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
[TBL] [Abstract][Full Text] [Related]
29. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.
Doran SE; Ren XD; Betz AL; Pagel MA; Neuwelt EA; Roessler BJ; Davidson BL
Neurosurgery; 1995 May; 36(5):965-70. PubMed ID: 7791989
[TBL] [Abstract][Full Text] [Related]
30. [Gene therapy of cerebral glioblastoma by adenovirus vector. Experimental model in the rat].
Dufour T; Quillien V; Heresbach N; Denais A; Ferry N; Guegan Y
Chirurgie; 1998 Apr; 123(2):168-74. PubMed ID: 9752539
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase.
Uchida M; Chen Z; Liu Y; Black KL
Neurol Res; 2002 Dec; 24(8):739-46. PubMed ID: 12500695
[TBL] [Abstract][Full Text] [Related]
32. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
33. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
34. Selective intraarterial gene delivery into a canine meningioma.
Chauvet AE; Kesava PP; Goh CS; Badie B
J Neurosurg; 1998 May; 88(5):870-3. PubMed ID: 9576256
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
36. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of nonviral gene transfer in the canine brain.
Oh S; Pluhar GE; McNeil EA; Kroeger KM; Liu C; Castro MG; Lowenstein PR; Freese A; Ohlfest JR
J Neurosurg; 2007 Jul; 107(1):136-44. PubMed ID: 17639883
[TBL] [Abstract][Full Text] [Related]
38. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated gene therapy of experimental gliomas.
Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
[TBL] [Abstract][Full Text] [Related]
40. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]